Clinical Trials: Psoriasis and Psoriatic Disorders

Alabama

Birmingham; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Arizona

Scottsdale; Radiant Research - Scottsdale
Clinical Research Study for Psoriasis

Arkansas

Hot Springs; Research Site:

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Little Rock; Research Site:

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Little Rock; Dermatology Research of Arkansas
A topical treatment for body psoriasis in adolescents

California

Burbank; Providence Clinical Research
Psoriasis Research Study

Fremont; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Fresno; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Los Angeles; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Riverside; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

San Diego; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

San Diego; Children’s Hospital San Diego
A topical treatment for body psoriasis in adolescents

Santa Monica; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Santa Monica; Research Site:

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Vallejo; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Florida

Miami; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Naples; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Pembroke Pines; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Pinellas Park; Radiant Research - St. Petersburg
Do you struggle with Psoriasis?

Tampa; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

West Palm Beach; Radiant Research - West Palm Beach
Do you struggle with Psoriasis?

West Palm Beach; Radiant Research - West Palm Beach
Psoriasis Affects Everyone Differently

Georgia

Alpharetta; Research Site:

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Conyers; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Marietta; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Hawaii

Honolulu; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Illinois

West Dundee; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Kentucky

Louisville; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Louisiana

New Orleans; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Slidell; Medical Research Institute, Inc.
A clinical research comparing the investigational use of an oral marketed drug to placebo for the treatment of moderate to severe chronic plaque psoriasis.

Maryland

Baltimore; PAREXEL at Harbor Hospital
Psoriasis Volunteers Needed

Massachusetts

Boston; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Worcester; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Michigan

Grand Blanc; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Saint Louis; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

St. Louis; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Troy; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Minnesota

Eagan; Dermatolgoy Center For Children & Young Adults, PA
A topical treatment for body psoriasis in adolescents

Missouri

St. Louis; Radiant Research - St. Louis
A skin infection may be something you try to hide. Our research study is looking to uncover new treatments.

St. Louis; Research Site
Study to evaluate the use of an INVESTIGATIONAL TOPICAL CREAM for the treatment of mild to moderate Psoriasis.

Nevada

Las Vegas; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Reno; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

New Hampshire

Lebanon; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

New Jersey

East Windsor; Research Site:

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

East Windsor; Psoriasis Treatment Center of Central New Jersey
A Phase III Multi-centered, Randomized, Double-blind, Placebo-controlled trial evaluating the efficacy and safety of CNTO 1275 in the treatment of subjects with moderate to severe plaque-type psoriasis

New Mexico

Albuquerque; Research Site:

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

New York

Bronx; Biomedical Research Alliance of New York
Clinical trial to test a study drug in plaque psoriasis

New York; Biomedical Research Alliance of New York
Moderate to Severe Chronic Plaque Psoriasis

New York; Biomedical Research Alliance of New York
Moderate to Severe Chronic Plaque Psoriasis

New York; Biomedical Research Alliance of New York
Mild to Moderate Plaque-type Psoriasis

New York; Biomedical Research Alliance of New York
Moderate to Severe Plaque Psoriasis

New York; Biomedical Research Alliance of New York
Clinical trial to test a study drug in people who have psoriasis

New York; Biomedical Research Alliance of New York
Clinical trial to test an experimental study drug in people with Moderate to Severe Chronic Plaque Psoriasis

New York; Biomedical Research Alliance of New York
Clinical trial to test an experimental study drug in people with Moderate to Severe Chronic Plaque Psoriasis

New York; Research Site:

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

New York; Biomedical Research Alliance of New York
Psoriasis Study Drug

New York; Biomedical Research Alliance of New York
Clinical trial to test a study drug in people with psoriasis.

New York; Biomedical Research Alliance of New York
Psoriasis

New York; Biomedical Research Alliance of New York
Randomized Study Comparing CNTO 1275 and Etanercept for the Treatment of Moderate to Severe Plaque Psoriasis

New York; Biomedical Research Alliance of New York
Chronic Plaque Psoriasis

New York; Biomedical Research Alliance of New York
Moderate psoriasis in adult subjects

New York; Biomedical Research Alliance of New York
People with plaque psoriasis who are planning on using Enbel for treatment are asked to participate in a research study being conducted by NYU School of Medicine.

New York; Biomedical Research Alliance of New York
Clinical trial to test a study drug in adults with chronic plaque psoriasis.

New York; Biomedical Research Alliance of New York
Clinical trial to test a study drug in adults with chronic plaque psoriasis

Rochester,; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Stony Brook; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Stony Brook; Research Site:

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Williamsville; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

North Carolina

Durham; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Winston-Salem; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Winston-Salem; Research Site:

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Oklahoma

Norman; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Oregon

Portland; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Portland; Radiant Research
Psoriasis

Pennsylvania

Exton; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Philadelphia; University of Pennsylvania Health System
Research study for the treatment of psoriasis.

Philadelphia; University of Pennsylvania Health System
Do you have psoriasis?

Philadelphia; Paddington Testing Co., Inc
A double-blind, placebo controlled, randomized, parallel group clinical trials of an investigational medication in patients with moderate to severe chronic plaque psoriasis vulgaris.

Pittsburgh; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Rhode Island

Johnston; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Johnston; Clinical Partners, LLC
Opportunity to participate: New Psoriasis Study Being Conducted

Johnston; Clinical Partners, LLC
Psoriasis?

Providence; Research Site:

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

South Carolina

Okatie; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Tennessee

Knoxville; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Nashville; Research Site:

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Texas

Houston; Research Site:

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Houston; Center for Clinical Studies
A topical treatment for body psoriasis in adolescents

San Antonio; Research Site:

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Virginia

Norfolk; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Washington

Bellingham; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Dayton; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Seattle; Dermatology Associates, PLLC
Psoriasis study for patients with moderate to severe plaque psoriasis using 2 different topical medications

Seattle; Research Center
A Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Seattle; Dermatology Associates, PLLC
Treatment of mild to moderate Psoriasis with protopic cream

Seattle; Dermatology Associates, PLLC
10 year long term observation of patient who are being treated with Tacrolimus

Seattle; Dermatology Associates, PLLC
5 year long term observation of patient who are being treated with Raptiva

Seattle; Dermatology Associates, PLLC
An open label pilot study to evaluate the efficacy and safety of Raptiva ® (efalizumab) in combination with narrow band phototherapy for the treatment of moderate to severe plaque psoriasis

Seattle; Dermatology Associates, PLLC
An open label pilot study to evaluate the efficacy and safety of Raptiva ® (efalizumab) in combination with narrow band phototherapy for the treatment of moderate to severe plaque psoriasis

Seattle; Dermatology Associates, PLLC
Registry of subjects on Enbrel ® (etanercept) for Treatment of Psoriasis

International

Belem, Brazil; Research Site:
A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.

Belo Horizonte, Brazil; Research Site:
A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.

Botucatu, Brazil; Research Site:
A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.

Brasilia, Brazil; Research Site:
A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.

Campinas, Brazil; Research Site:
A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.

Curitiba, Brazil; Research Site:
A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.

Rio De Janeiro, Brazil; Research Site:
A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.

Salvador, Brazil; Research Site:
A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.

Sao Paulo, Brazil; Research Site:
A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.

St. John's, Newfoundland, Canada; Newlab Clinical Research, Inc.
A topical treatment for body psoriasis in adolescents


Back to Clinical Trials by Medical Areas

Research centers
specializing in
this illness area

Additional resources
in this illness area

International Listings

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listing updated: September 2, 2008 at 3:08:07 PM

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA